We present common cytogenetic features in the largest cohort of plasmablastic lymphoma (PBL) of the oral cavity published to date. This cohort included 45 patients, 32 of whom had a known HIV status, of which thirty one were HIV positive. Ninety eight per cent of all PBL cases were known to be EBV positive. In line with previous studies, we found that rearrangements of the MYC gene was the most common genetic abnormality seen in 60% of cases with the immunoglobulin heavy chain (IGH) locus as a partner in 51% of cases. Additional complex genetic aberrations were frequent, in particular, an increased copy number of the CCND1 gene was seen in 41% of cases with true amplification of CCND1 in 15% of cases. Aneuploidy was also observed for the BCL6 gene in 28% of cases. Interestingly, rearrangements of both IGH genes were detected in 16% of cases with t(14;18) and t(11;14) respectively involved in conjunction with a t(8;14) in two cases. These bi-allelic IGH rearrangements have not been described before in oral PBL. Our results reinforce the notion that EBV infection and MYC rearrangements are important events in the pathogenesis of oral PBL. The genetic diversity and complexity observed in these cases, underlines the importance to genetically characterise PBL patients at presentation as this may inform the choice of more effective treatment modalities.
Introduction
Plasmablastic lymphoma (PBL) is a highly aggressive tumour that consist of large, neoplastic terminally differentiated B-cells 1 . This lymphoma is currently recognised as a distinct entity with well documented morphological and immunophenotypic features 2 . However, the pathogenesis of this disease has not been fully elucidated and the normal cell counterpart from which PBL takes origin is still to be determined. It is difficult to distinguish PBL from extramedullary plasmacytomas (EMPC) or multiple myeloma (MM) with plasmablastic morphology and the possibility that PBL may be related to these neoplasms has previously been proposed 1, 3, 4 .
Most PBL cases are associated with immunodeficiency, and particularly HIV/AIDS related immunodeficiency. Infections with other viruses, especially the Epstein Barr virus (EBV) are frequently associated with PBL and the reported incidence vary from 60 to 100% 1, 3, 5 , but the role of EBV in the pathogenesis remains unexplained. A possible aetiological role of the human herpesvirus-8 (HHV-8) has previously been proposed [6] [7] [8] but the presence of HHV-8 currently rules against the diagnosis of PBL 1,2 .
Recently Valera et al, reported on the morphology immunophenotype and genetic features of a large series of 42 PBL's cases from various anatomical locations. Their study highlighted the importance of MYC gene rearrangements (49%) mostly with the imunoglobulin heavy chain gene (IGH) 5 . This confirmed previous case reports and small series that suggest an important role for MYC in the pathogenesis of PBL 3,9-12 . In addition, Valera and co-workers described frequent gains of MYC, IGH and other loci commonly involved in B-cell lymphoma 5 .
Despite these recent data, there is a significant shortage of genetic studies on this neoplasm likely due to its overall rarity, apart from countries with high incidences of HIV/AIDS. We recently published the clinico-pathologic, immunophenotypic and viral features of 45 PBL cases all affecting the oral mucosa 1 and we report here the genetic aberrations in what represents the largest series of PBL's affecting the oral mucosa to date.
Materials and methods

Case selection and clinical features
Forty-five cases confirmed as PBL using the WHO classification criteria 2 , were retrieved from the files of the Departments of Oral Pathology at the Universities of Pretoria and Limpopo, South
Africa. The clinical information and HIV status of all cases were obtained from the pathology request forms. The group consisted of 31 males, 12 females and 2 of unknown gender. Two patients were white males, 1 was of unknown race and the rest were black. The male to female ratio was 2,6:1.
The mean age of the patients was 41years (29-58years microscope equipped with a spectrum-green, orange, aqua, DAPI and triple band filters. FISH slides were screened by three independent analysts for verification of the results and selected images were captured using the GenusTM CytoVision 3.0 software (Applied Imaging). Slides were scored based on the knowledge of background levels of BA and fusion patterns in normal lymphoid tissue using at least 100 nuclei counts. Cut-off values for the FISH analysis were 5% for the BA probes and 15% for the dual fusion probes.
Results
FISH analysis
The combined results of FISH analysis, EBV positivity and HIV status are summarized in The CCND1/IGH probe was hybridized to 41 specimens. The CCND1 gene was found to be involved in a translocation with IGH in only one case, but interestingly, increased CCND1 copy numbers were observed in 17 of 41 cases (41%) with 10 cases having three to five signals and seven cases having cells with more than six copies (Fig. 1) . With the same probe set, six cases of PBL also showed gains of the IGH gene (Table 1) .
Of the seven lymphomas with rearrangement of both IGH genes, two cases had a t(8;14) in association with a t(11;14) and a t(14;18) respectively; these were therefore double hit lymphomas.
In three cases MYC was one of the IGH translocation partners while the other partner was not identified and both IGH chromosome partners remained unknown in two additional cases.
No rearrangements of BCL6 gene could be detected in any of the 40 PBL's screened with the BCL6 probe but gains with three to seven fusion signals per cell were observed in 11 cases (28%).
There was no correlation between the genetic features described here and the histomorphologic features such as the presence of plasmacytic differentiation. There was also no correlation between the immunohistochemical staining pattern for CD45, CD79a, CD138, CD38, MUM or the kappa and lambda light chains and the genetic features in any individual case of PBL included in this study.
Discussion
Thirty-one of the 32 patients (97%) with a known HIV-status in our study were HIV positive 1 .
In South Africa PBL is a neoplasm mostly related to HIV infection and we concur with others that the varies from a few weeks to 3 years but seems to be reduced substantially when MYC rearrangements are present [9] [10] [11] .
In the largest genetic study on PBL reported to date by Valera et al., the incidence of MYC rearrangement was 49%. Their PBL cases were however from various anatomical locations and MYC rearrangements were more frequent in EBV-positive patients who represented less than 60% of their cohort 5 . Their series included eight cases of PBL of the oral mucosa, five of which (63%) had a MYC rearrangement and two cases with gains associated with MYC 5 . We observed MYC rearrangement in 60% of oral PBL in our series and 98% of these cases (44/45) were known to be EBV positive 1 . EBV may thus be critical in the initiation of PBL of the oral cavity. The Waldeyer ring of lymphoid tissue, as well as the posterior oro-pharyngeal and naso-pharyngeal epithelial cells, is considered to act as EBV reservoirs 24 . EBV reactivation during HIV infection might be explained by the decline of EBVspecific memory CD4+ and CD8+ T-cell responses 25 . Of note, in our series, the only EBV-negative PBL was from a HIV negative patient, who also had no MYC or IGH rearrangements. The cooperation of EBV oncoviral proteins with the products of MYC gene aberrations may be the main pathogenic event for the development of lymphomas such as PBL and should be investigated further [26] [27] [28] .
Some mechanisms have been proposed to account for the aggressiveness of non-Burkitt's lymphoma with MYC gene rearrangements and the possibility that MYC may modulate different set of gene targets in non-BL when compared to BL was recently postulated 23 . In addition MYC gene rearrangements in non BL are often associated with added cytogenetic abnormalities which may further contribute to the aggressive behaviour of the disease and to poor response to therapy observed in these patients 5, 12 . Seven PBL's cases in our series showed rearrangement of both IGH alleles.
Both IGH translocation partners were unidentified in two cases, while MYC was one of the IGH partner in five cases. Among the latter, two cases showed involvement of the CCND1 and BCL2
genes respectively together with a MYC/IGH rearrangement. "Double hits" of IGH have been reported in several DLBCL and particularly in large B cell lymphoma with intermediate features between DLBCL and BL 2 . To the best of our knowledge, the finding of rearrangement of both IGH alleles, although of low frequency (16%), is a new observation in PBL.
The CCND1 gene was increased in copy number in 17/41 cases (41%), with more than six copies in seven of these cases. Cases with multiple CCND1 copies suggest true amplification of this gene in some oral PBL. Cyclin D1 is a key cell cycle regulatory protein 29 and its increased gene copy number may drive uncontrolled cell proliferation and contribute to the high proliferation index and aggressive clinical course of PBL. CCND1 gene amplification has been described in aggressive B-7 cell NHL's 30 as well as in MM, in which case various mechanisms can be responsible for CCND1 over-expression 31, 32 . To our knowledge CCND1 amplification has not previously been described in PBL.
Although no rearrangements of BCL6 were detected, gains of this gene were also observed in 11/40 (28%) of cases. Less than six copies were seen, likely to represent aneuploidy, further contributing to the complex cytogenetic features of these lymphomas.
Therapeutic approaches specific for MYC-associated lymphomas are lacking but bortezomib, a proteasome inhibitor widely used in the treatment of MM, is known to down regulate MYC 33 . This might explain the recently reported dramatic response of a patient with PBL of the stomach to bortezomib treatment 4 . This study underlines the importance of routine evaluation of MYC rearrangements in PBL cases as this may have prognostic and treatment choice implications 10 .
There are no definite distinguishing features between PBL and MM or PBL and EMPC with plasmablastic morphology and the diagnostic boundaries between these neoplasms are sometimes blurred. Neither the patient HIV status nor the EBV positivity of the tumour helps to differentiate these neoplasms. Clinico-pathologic features of MM can be obscured in HIV/AIDS patients [34] [35] [36] and cases described as PBL in the literature had clinical characteristics of MM such as monoclonal serum immunoglobulin 3 and radiographically evident disseminated bone involvement 9, 35, 37, 38 . It is therefore clear that clinical features also do not serve as distinguishing features between these neoplasms.
Although the high incidence of IGH rearrangement [39] [40] [41] and increased CCND1 copy number echoes features of MM, the true relationship between these neoplasms should be investigated further.
In conclusion, PBL is a genetically complex neoplasm often associated with immunosuppression, particularly HIV/AIDS. We suggest that PBL of the oral cavity should be included as a group 1 lesion in the EC Clearinghouse and WHO Collaborating Centre classification of oral problems related to HIV infection 42 , especially in countries with high incidences of HIV such as South Africa. Our results, in line with others, reinforce the notion that EBV infection and MYC rearrangement are important events in the pathogenesis of oral PBL. Interestingly we have observed in our cohort rearrangements of both IGH alleles with two "double hit" cases as well as amplification of CCND1 described in PBL for the first time.
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